The Latest

  • A wall bearing the Johnson & Johnson logo is seen outside of an office building.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J’s cardiovascular unit stands out again in Q1

    Johnson & Johnson’s strategic shift to higher growth medical device markets like cardiovascular is paying off, as the business was the only medtech unit to grow by double digits in the first quarter.

  • Close-up of gloved hands handling a sealed medical package containing sterile equipment in a clinical setting.
    Image attribution tooltip

    iStock / Carmen Ruiz Alonso

    Image attribution tooltip
    Sponsored by PAXXUS

    The seal strength paradox: Why more is not always better in sterile barrier packaging

    What really determines seal performance in sterile packaging?

  • A modern industrial building with beige and white walls and large blue-tinted glass windows. The name “Stryker” is mounted in black letters on the upper portion of the building. A white smokestack protrudes from the roof, and the sky is light and partly cloudy.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Stryker to buy Amplitude Vascular Systems

    Amplitude’s intravascular lithotripsy technology could emerge as a challenger to Shockwave IVL, Leerink Partners analyst Mike Kratky wrote.

  • A crowd watches the president sign an executive order in the Rose Garden of the White House.
    Image attribution tooltip
    Andrew Harnik / Staff via Getty Images
    Image attribution tooltip
    Deep Dive

    One year in: How medtech companies are coping with tariff challenges

    A resilient medtech industry navigating the fallout from President Donald Trump’s trade wars is taking proactive steps to manage tariff costs as the administration’s policies continue to evolve.

  • A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland.
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    Medline recalls angiographic syringes, receives FDA warning letter

    The company removed the devices from the market in February following complaints of the syringes disconnecting from manifolds.

  • Medtronic's Stealth AXiS system.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    GE HealthCare integrates ultrasound into Medtronic’s Stealth AXiS surgical system

    Partnering with GE HealthCare has enabled Medtronic to provide live images to help surgeons assess mid-procedure changes.

  • A modern industrial building with beige and white walls and large blue-tinted glass windows. The name “Stryker” is mounted in black letters on the upper portion of the building. A white smokestack protrudes from the roof, and the sky is light and partly cloudy.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Stryker is fully operational after cyberattack

    The company disclosed that it expects a material impact on first-quarter financial results. However, it does not expect an effect on full-year results.

  • Pulse Biosciences' pulsed field ablation tool is displayed against a white background.
    Image attribution tooltip
    Permission granted by Pulse Biosciences
    Image attribution tooltip

    Pulse Biosciences hires Liane Teplitsky as COO

    The appointment gives a former Abbott leader oversight of efforts to bring a pulsed field ablation device to market.

  • A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland.
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA, medtech industry near MDUFA VI agreement

    The FDA said it intends to hire “substantial numbers” of medical device review staff as part of the agreement for the next medical device user fee amendments.

  • A stylized collage centers on a handheld medical device resembling a glucose monitor, overlaid on bold red and blue geometric shapes, with faint overhead images of empty office desks in the background and the word “REJECTED” repeated in gray text.
    Image attribution tooltip

    Photo illustration: Mark Harris

    Image attribution tooltip
    Deep Dive

    ‘Cracks show’ as CDRH staff contend with heavy workloads

    Former device leaders said a culture of “fear and anxiety” has driven experienced staff from the Food and Drug Administration. An overburdened workforce has affected communications from the agency.

  • A mechanical thrombectomy device is shown against a white background.
    Image attribution tooltip
    Courtesy of Endovascular Engineering
    Image attribution tooltip

    E2 raises $80M to market thrombectomy platform

    The funding round follows high-profile acquisitions by Boston Scientific and Stryker to pick up mechanical thrombectomy devices for blood clot removal.

  • A concrete sign outside of a building reads "Department of Health & Human Services" wrapped around the HHS logo.
    Image attribution tooltip
    Kayla Bartkowski via Getty Images
    Image attribution tooltip

    Judge allows states’ lawsuit over HHS restructuring to move forward

    A group of 19 states and Washington, D.C., sued over the department’s sweeping layoffs and reorganization last year. A federal judge on Tuesday struck down the HHS’ bid to dismiss the lawsuit.

  • A person sits in a chair in while another person attaches a blood pressure cuff on their arm. In the background is a wall with several framed photos.
    Image attribution tooltip
    John Moore via Getty Images
    Image attribution tooltip

    CDRH targets hospital readmissions with home device innovation challenge

    The center plans to pick nine devices to help support patients and caregivers after a hospital stay.

  • Professional photo of Joe Almeida
    Image attribution tooltip
    Permission granted by Baxter
    Image attribution tooltip

    Hologic hires former Baxter leader José Almeida as CEO

    The company appointed Almeida as chief executive in conjunction with the completion of an $18.3 billion go-private deal.

  • Philips, Trilogy, evo, respirator
    Image attribution tooltip
    Courtesy of Philips
    Image attribution tooltip

    Philips warns not to use certain nebulizers in Trilogy Evo ventilator recall

    Using non-pneumatic nebulizers with the ventilators can lead to under-delivery of therapy to patients, the company said.

    Updated April 9, 2026